MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 6, 2005; DOI: 10.1124/mol.105.016923


0026-895X/06/6901-66-75$20.00
Mol Pharmacol 69:66-75, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.016923v1
69/1/66    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, M.
Right arrow Articles by Schraufstatter, I. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, M.
Right arrow Articles by Schraufstatter, I. U.

Regulation of CXCR4-Mediated Nuclear Translocation of Extracellular Signal-Related Kinases 1 and 2

Ming Zhao, Richard G. DiScipio, Antonia G. Wimmer1, and Ingrid U. Schraufstatter

Division of Cancer Biology, La Jolla Institute for Molecular Medicine, San Diego, California

Activation of the chemokine receptor CXCR4 by its agonist stromal cell-derived factor 1 (SDF-1) has been associated with cell migration and proliferation in many cell types, but the intracellular signaling cascades are incompletely defined. Here we show that CXCR4-dependent extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation was mediated through the Ras/Raf pathway, as demonstrated with a dominant-negative Ras mutant and pharmacological inhibitors. The Src inhibitor 4-amino-5-methylphenyl-7-(t-butyl)pyrazolo[3,4-d] pyrimidine (PP1) and the Rho-kinase (ROCK) inhibitor N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide dihydrochloride (Y27632) also attenuated SDF-1-induced ERK1/2 phosphorylation. Involvement of Src could furthermore be demonstrated by Src phosphorylation and by the shortened ERK1/2 phosphorylation in SYF cells, which are Src/Yes/Fyn-deficient compared with Src-reconstituted Src++ cells. Membrane translocation of RhoA could be detected similarly. A large portion of the SDF-1-mediated ERK phosphorylation was detected in the nucleus, as shown by Western blotting and confocal microscopy, and resulted in the phosphorylation of the transcription factor Elk. It is interesting that the nuclear accumulation of ERK1/2 and Elk phosphorylation was completely blocked by dominant-negative Rho, Y27632, PP1, and latrunculin B, indicating that the Rho/ROCK pathway, Src kinase, and the actin cytoskeleton were required in this process. In accordance, neither nuclear ERK phosphorylation nor Elk phosphorylation were observed in SYF cells stimulated with SDF-1 but were reconstituted in Src++ cells. In summary, these results demonstrate that Src, Rho/ROCK, and an intact cytoskeleton contribute to overall ERK1/2 activation in SDF-1-stimulated cells and are indispensable for nuclear translocation of ERK1/2 and activation of transcription factors.


Received July 15, 2005; accepted October 5, 2005

Address correspondence to: Dr. Ming Zhao, Division of Cancer Biology, La Jolla Institute for Molecular Medicine, 4570 Executive Drive, Suite 100, San Diego, CA 92121. E-mail: mzhao{at}ljimm.org




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. L. Wagner, E. Hyjek, M. F. Vazquez, D. Meherally, Y. F. Liu, P. A. Chadwick, T. Rengifo, G. L. Sica, J. L. Port, P. C. Lee, et al.
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 615 - 621.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Wong and W. Korz
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Clin. Cancer Res., December 15, 2008; 14(24): 7975 - 7980.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R M Thomas, J Kim, M P Revelo-Penafiel, R Angel, D W Dawson, and A M Lowy
The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
Gut, November 1, 2008; 57(11): 1555 - 1560.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie
CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Blood, July 1, 2008; 112(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Pan, C. Luo, R. Li, A. Qiao, L. Zhang, M. Mines, A. M. Nyanda, J. Zhang, and G.-H. Fan
Cyclophilin A Is Required for CXCR4-mediated Nuclear Export of Heterogeneous Nuclear Ribonucleoprotein A2, Activation and Nuclear Translocation of ERK1/2, and Chemotactic Cell Migration
J. Biol. Chem., January 4, 2008; 283(1): 623 - 637.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. J. Goetzl
Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands
FASEB J, March 1, 2007; 21(3): 638 - 642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Li, C. Luo, M. Mines, J. Zhang, and G.-H. Fan
Chemokine CXCL12 Induces Binding of Ferritin Heavy Chain to the Chemokine Receptor CXCR4, Alters CXCR4 Signaling, and Induces Phosphorylation and Nuclear Translocation of Ferritin Heavy Chain
J. Biol. Chem., December 8, 2006; 281(49): 37616 - 37627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Luo, H. Pan, M. Mines, K. Watson, J. Zhang, and G.-H. Fan
CXCL12 Induces Tyrosine Phosphorylation of Cortactin, Which Plays a Role in CXC Chemokine Receptor 4-mediated Extracellular Signal-regulated Kinase Activation and Chemotaxis
J. Biol. Chem., October 6, 2006; 281(40): 30081 - 30093.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics